Enhancing effector cell durability and efficacy in adoptive cell therapies
US-2025388646-A1 · Dec 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Peralta Eigen patents
Peralta Eigen is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Peralta Eigen |
| Total patents | 26 |
| First publication | Jan 21, 2016 |
| Latest publication | Dec 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-12419870-B2 · Sep 23, 2025 · US
Cells having solid tumor targeting backbone and use thereof
US-2025228943-A1 · Jul 17, 2025 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2025215396-A1 · Jul 3, 2025 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-12281329-B2 · Apr 22, 2025 · US
Effector cells and use thereof for allogeneic adoptive cell therapies in solid tumors
US-2025032547-A1 · Jan 30, 2025 · US
Cells having solid tumor targeting backbone and use thereof
US-12203098-B2 · Jan 21, 2025 · US
Effector cells and use thereof for allogeneic adoptive cell therapies in solid tumors
US-2025000904-A1 · Jan 2, 2025 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2024263135-A1 · Aug 8, 2024 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-12036241-B2 · Jul 16, 2024 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-11932870-B2 · Mar 19, 2024 · US
ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS
US-2024033355-A1 · Feb 1, 2024 · US
Engineered ipsc and persistent immune effector cells
US-2023390337-A1 · Dec 7, 2023 · US
Cells having solid tumor targeting backbone and use thereof
US-2023357716-A1 · Nov 9, 2023 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2022401487-A1 · Dec 22, 2022 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-11413309-B2 · Aug 16, 2022 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2021393695-A1 · Dec 23, 2021 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-11096964-B2 · Aug 24, 2021 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2020179451-A1 · Jun 11, 2020 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2020181573-A1 · Jun 11, 2020 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2019282618-A1 · Sep 19, 2019 · US
Compositions and methods for immune cell modulation in adoptive immunotherapies
US-2019125795-A1 · May 2, 2019 · US
Oligomeric Compounds and Compositions for use in Modulation of Small Non-Coding RNAs
US-2019062744-A1 · Feb 28, 2019 · US
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US-2017268002-A1 · Sep 21, 2017 · US
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US-2017037402-A1 · Feb 9, 2017 · US
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US-2016017329-A1 · Jan 21, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Fate Therapeutics Inc | 22 |
| Regulus Therapeutics Inc | 4 |
| Juno Therapeutics Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K40/11 | 22 |
| C12N5/0636 | 22 |
| C12N2510/00 | 21 |
| A61P35/00 | 19 |
| A61K40/31 | 17 |